ISSN: 1078-0998

Journal Home

Journal Guideline

Inflammatory Bowel Diseases Q1 Unclaimed

Oxford University Press United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Inflammatory Bowel Diseases is a journal indexed in SJR in Immunology and Allergy and Gastroenterology with an H index of 153. It has an SJR impact factor of 1.706 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1.706.

Inflammatory Bowel Diseases focuses its scope in these topics and keywords: inflammatory, bowel, disease, patients, crohn?s, clinical, colitis, ulcerative, intestinal, pediatric, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Gastroenterology (Q1) Immunology and Allergy (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1.706

SJR Impact factor

153

H Index

322

Total Docs (Last Year)

965

Total Docs (3 years)

10084

Total Refs

4281

Total Cites (3 years)

697

Citable Docs (3 years)

3.83

Cites/Doc (2 years)

31.32

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Immunology Q1
Journal of Experimental Medicine Q1
Lancet Rheumatology, The Q1
Journal of Cellular Immunotherapy Q1
Annals of the Rheumatic Diseases Q1

Compare this journals

Aims and Scope

Best articles by citations

THREE STRIKES AND YOU'RE OUT - INTERLEUKIN-10 IN CROHN'S DISEASE

CROHN'S DISEASE AND IL-10 THERAPY: PROMISE REGAINED?

GROWTH OF AN IBD CONTROVERSY: GROWTH HORMONE AND CROHN'S DISEASE

AN ENHANCED BARRIER IS A BETTER DEFENSE: EFFECTS OF PROBIOTICS ON INTESTINAL BARRIER FUNCTION

Intravenous Cyclosporine in Refractory Pyoderma Gangrenosum Complicating Inflammatory Bowel Disease

Intravenous Cyclosporine in Severe Ulcerative Colitis: How Low Can You Go?

Crohn's Jejunoileitis: The Pediatrician's Perspective on Diagnosis and Management

Colonoscopic Findings in Intestinal Behçet's Disease

Epstein-Barr Virus Viral Load in Crohn's Disease

Interleukin-2-Deficient Mice Develop Colitis in the Absence of CD28 Costimulation

Intra- and Interobserver Variation in the Use of the Vienna Classification of Crohn's Disease

Mechanisms of Infliximab

SHOW MORE ARTICLES

Is Infliximab Effective for Induction of Remission in Patients with Ulcerative Colitis?

CHRONIC DIARRHEA: TO SCOPE OR NOT TO SCOPE?

Immune Sensitization to Yeast Antigens in ASCA-positive Patients with Crohn's Disease

Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: Prevalence and risk factors

The Incidence of Lymphoid and Myeloid Malignancies Among Hospitalized Crohn's Disease Patients

Medical Management of Fulminant Colitis

Novel Biological Strategies in Inflammatory Bowel Diseases

Ocular Manifestations of Inflammatory Bowel Disease

WHAT YOU DON'T KNOW MIGHT HURT YOU...

Giving the NOD to a New Understanding of Crohn's Disease: Mother Nature Has Finally Started to Show her CARDs

Support for Suppositories

Mucosal Immunity in Crohn's Disease